Iida Tomoko, Fujinaka Hidehiko, Xu Bo, Zhang Ying, Magdeldin Sameh, Nameta Masaaki, Liu Zan, Yoshida Yutaka, Yaoita Eishin, Tomizawa Shuichi, Saito Akihiko, Yamamoto Tadashi
Institute for Clinical Research, Niigata National Hospital, 3-52 Akasaka-cho, Kashiwazaki, 945-8585, Japan.
Clin Exp Nephrol. 2014 Jun;18(3):432-43. doi: 10.1007/s10157-013-0835-3. Epub 2013 Jul 18.
Several proteins have been proposed as new urinary biomarkers of kidney injuries, but they are not always capable of identifying the kidney nephron segment that has been injured. Since calbindin 1 protein is exclusively localized in the kidney distal nephron segment, it is presumed that its expression is altered during distal nephron segment injuries, resulting in changes in its urinary excretion.
Calbindin 1 expression in normal rat kidneys was compared with that in the kidneys of rats that had suffered distal nephron segment injuries (unilateral ureteral obstruction [UUO] or anti-glomerular basement membrane glomerulonephritis [anti-GBM GN]) using immunohistochemical examinations and real-time polymerase chain reaction. The urinary calbindin 1 protein concentration of normal rats was also compared with that of anti-GBM GN rats and of cisplatin nephropathy rats using Western blotting. We also compared the kidney and urinary calbindin 1 protein concentrations of normal human subjects with those of proteinuric patients [immunoglobulin (Ig)A nephropathy; IgAN] with distal nephron segment injuries.
Calbindin 1 mRNA expression in the renal cortices and calbindin 1 protein expression in the kidney distal nephron segments were decreased in the UUO and anti-GBM GN rat kidneys. The urinary calbindin 1 protein levels of the anti-GBM GN rats were also markedly decreased, whereas those of the cisplatin nephropathy rats were slightly decreased. The human IgAN patients displayed decreased renal calbindin 1 protein expression in their dilated distal tubules, and some patients displayed decreased urinary calbindin 1 levels.
Since it has been demonstrated that decreased urinary calbindin 1 levels are indicative of decreased calbindin 1 kidney expression due to distal nephron segment injuries, calbindin 1 might be a useful urinary biomarker for identifying distal nephron segment injuries.
已有多种蛋白质被提议作为肾损伤的新型尿液生物标志物,但它们并不总能识别出受损的肾单位节段。由于钙结合蛋白1仅定位于肾脏远曲小管节段,推测其在远曲小管节段损伤时表达会发生改变,导致其尿排泄量变化。
采用免疫组化检查和实时聚合酶链反应,比较正常大鼠肾脏与远曲小管节段损伤大鼠(单侧输尿管梗阻[UUO]或抗肾小球基底膜肾小球肾炎[抗GBM GN])肾脏中钙结合蛋白1的表达。还使用蛋白质印迹法比较了正常大鼠与抗GBM GN大鼠及顺铂肾病大鼠的尿钙结合蛋白1浓度。我们还比较了正常人类受试者与患有远曲小管节段损伤的蛋白尿患者[免疫球蛋白(Ig)A肾病;IgAN]的肾脏和尿钙结合蛋白1浓度。
UUO和抗GBM GN大鼠肾脏中肾皮质钙结合蛋白1 mRNA表达及肾脏远曲小管节段钙结合蛋白1蛋白表达均降低。抗GBM GN大鼠的尿钙结合蛋白1水平也显著降低,而顺铂肾病大鼠的尿钙结合蛋白1水平略有降低。人类IgAN患者扩张的远曲小管中肾钙结合蛋白1蛋白表达降低,部分患者尿钙结合蛋白1水平降低。
由于已证明尿钙结合蛋白1水平降低表明远曲小管节段损伤导致肾脏中钙结合蛋白1表达降低,钙结合蛋白1可能是识别远曲小管节段损伤的有用尿液生物标志物。